共 50 条
- [2] Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT [J]. FEBS OPEN BIO, 2024, 14 (05): : 831 - 842
- [4] Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells [J]. Scientific Reports, 10
- [6] MiR-630 inhibits cells migration and invasion by targeting SOX4 in triple-negative breast cancer [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9097 - 9105